|
GANX Gain Therapeutics Inc 1819411 |
| Balance Sheet |
|
Current Assets
|
13,741,340 |
|
Assets
|
14,365,664 |
|
Current Liabilities
|
4,594,795 |
|
Liabilities
|
5,456,282 |
|
Equity
|
8,909,382 |
|
Shares Out
|
25,535,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-15,419,191 |
|
Investing Cash Flow
|
5,020,954 |
| Market Analysis |
Market Cap
|
37,409,442 |
|
Price
|
2.35 |
|
BVPS
|
0.35 |
|
PB
|
7.17 |
|
EPS
|
-1.33 |
|
PS
|
0.10 |
|
FCF
|
-10,398,237 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GANX documents filed with the SEC.
GANX Filings
Clear
